232 related articles for article (PubMed ID: 12909217)
1. Effect of treatment time on outcome of radiotherapy for oral tongue carcinoma.
Hosokawa Y; Shirato H; Nishioka T; Tsuchiya K; Chang TC; Kagei K; Ohomori K; Obinata K; Kaneko M; Miyasaka K; Nakamura M
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):71-8. PubMed ID: 12909217
[TBL] [Abstract][Full Text] [Related]
2. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.
Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Matsuura K; Ito K
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):767-75. PubMed ID: 10386633
[TBL] [Abstract][Full Text] [Related]
3. Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy.
Wendt CD; Peters LJ; Delclos L; Ang KK; Morrison WH; Maor MH; Robbins KT; Byers RM; Carlson LS; Oswald MJ
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1287-92. PubMed ID: 2370178
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth.
Bachaud JM; Delannes M; Allouache N; Benchalal M; Alzieu C; David JM; Serrano E; Daly-Schveitzer NJ
Radiother Oncol; 1994 Jun; 31(3):199-206. PubMed ID: 8066202
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers.
Gibbs IC; Le QT; Shah RD; Terris DJ; Fee WE; Goffinet DR
Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):489-94. PubMed ID: 12957261
[TBL] [Abstract][Full Text] [Related]
6. Base-of-tongue carcinoma: treatment results using concomitant boost radiotherapy.
Mak AC; Morrison WH; Garden AS; Ang KK; Goepfert H; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):289-96. PubMed ID: 7673016
[TBL] [Abstract][Full Text] [Related]
7. High-dose-rate interstitial brachytherapy boost in inoperable locally advanced tongue carcinoma.
Santos MA; Guinot JL; Tortajada MI; Santamaría P; Campo V; Oliver L; Peña M; Arribas L
Brachytherapy; 2017; 16(6):1213-1218. PubMed ID: 28807749
[TBL] [Abstract][Full Text] [Related]
8. Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins.
Lapeyre M; Hoffstetter S; Peiffert D; Guérif S; Maire F; Dolivet G; Toussaint B; Mundt A; Chassagne JF; Simon C; Bey P
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):37-42. PubMed ID: 10924969
[TBL] [Abstract][Full Text] [Related]
9. An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue.
Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Ohtani K; Wada T
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):333-9. PubMed ID: 8567334
[TBL] [Abstract][Full Text] [Related]
10. T1 and T2 squamous cell carcinomas of the floor of the mouth: results of brachytherapy mainly using 198Au grains.
Matsumoto S; Takeda M; Shibuya H; Suzuki S
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):833-41. PubMed ID: 8598360
[TBL] [Abstract][Full Text] [Related]
11. High dose rate brachytherapy for early stage oral tongue cancer.
Leung TW; Wong VY; Kwan KH; Ng TY; Wong CM; Tung SY; Leung LC; O SK
Head Neck; 2002 Mar; 24(3):274-81. PubMed ID: 11891960
[TBL] [Abstract][Full Text] [Related]
12. Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors.
Chyle V; Zagars GK; Wheeler JA; Wharton JT; Delclos L
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):891-905. PubMed ID: 8751398
[TBL] [Abstract][Full Text] [Related]
13. High-dose-rate brachytherapy using molds for lip and oral cavity tumors.
Unetsubo T; Matsuzaki H; Takemoto M; Katsui K; Hara M; Katayama N; Waki T; Kanazawa S; Asaumi J
Radiat Oncol; 2015 Apr; 10():81. PubMed ID: 25888772
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers.
Bhalavat RI; Mahantshetty UM; Tole S; Jamema SV
J Cancer Res Ther; 2009; 5(3):192-7. PubMed ID: 19841561
[TBL] [Abstract][Full Text] [Related]
15. [ORL brachytherapy. Brachytherapy of epidermoid carcinoma of the oral cavity].
Haie-Meder C; Marsiglia H; Mamelle G; Wibault P; Lartigau E; Gerbaulet A
Bull Cancer Radiother; 1995; 82(2):186-90. PubMed ID: 7546889
[No Abstract] [Full Text] [Related]
16. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer.
Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
Radiother Oncol; 2003 Aug; 68(2):123-8. PubMed ID: 12972306
[TBL] [Abstract][Full Text] [Related]
17. Postoperative interstitial brachytherapy for resectable squamous cell carcinoma of the tongue.
Goineau A; Piot B; Malard O; Ferron C; Lisbona A; Cassagnau E; Delamazure AS; Campion L; Bardet E
Brachytherapy; 2015; 14(1):71-6. PubMed ID: 25454575
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of local outcome for T1, T2 carcinomas of oral tongue treated by iridium 192 implantation.
Mazeron JJ; Crook JM; Marinello G; Walop W; Pierquin B
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):281-5. PubMed ID: 2394607
[TBL] [Abstract][Full Text] [Related]
19. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM
Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587
[TBL] [Abstract][Full Text] [Related]
20. Treatment duration as a prognostic factor for local control and survival in epidermoid carcinomas of the tonsillar region treated by combined external beam irradiation and brachytherapy.
Hoffstetter S; Marchal C; Peiffert D; Luporsi E; Lapeyre M; Pernot M; Bey P
Radiother Oncol; 1997 Nov; 45(2):141-8. PubMed ID: 9424004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
